Eledon Pharmaceuticals (ELDN) Return on Equity [ROE] (2014 - 2026)
Eledon Pharmaceuticals' Return on Equity [ROE] was -225.91% in Q2 2026, down 64.94 percentage points from -160.97% a year earlier and down 94.09 percentage points from the prior quarter.
Powered by 
Analysis
Eledon Pharmaceuticals (ELDN) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Eledon Pharmaceuticals came in at -63.56%, up 454.83 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -40.76 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -518.40% in FY2024, -93.69% in FY2022 (-74.23 pp) and -19.46% in FY2021 (+3.34 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q3 2023.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 118.24 percentage points); the worst was Q3 2023 (a drop of 203.00 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Eledon Pharmaceuticals | 282.94 Mn | 282.94 Mn | - | -225.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -225.91% |
| Mar 31, 2026 | -131.82% |
| Sep 30, 2025 | -201.79% |
| Jun 30, 2025 | -160.97% |
| Mar 31, 2025 | -128.03% |
| Dec 31, 2024 | -170.46% |
| Sep 30, 2023 | -229.44% |
| Jun 30, 2023 | -152.36% |
| Mar 31, 2023 | -180.99% |
| Dec 31, 2022 | -106.70% |
| Sep 30, 2022 | -26.43% |
| Jun 30, 2022 | -24.69% |
| Mar 31, 2022 | -22.40% |
| Dec 31, 2021 | -20.62% |
| Sep 30, 2021 | -18.33% |
| Jun 30, 2021 | -15.64% |
| Mar 31, 2021 | -12.57% |
| Dec 31, 2020 | -21.89% |
| Sep 30, 2020 | -136.57% |
| Jun 30, 2020 | -169.19% |
API Access
Eledon Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ELDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();